Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
18.94
+0.40 (2.16%)
At close: Sep 26, 2025, 4:00 PM EDT
18.93
-0.01 (-0.05%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 12 analysts that cover Healthpeak Properties stock have a consensus rating of "Buy" and an average price target of $21.25, which forecasts a 12.20% increase in the stock price over the next year. The lowest target is $18 and the highest is $26.
Price Target: $21.25 (+12.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 6 | 6 | 6 | 5 | 6 | 7 |
| Hold | 3 | 3 | 2 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Hold → Buy Upgrades $20 | Hold → Buy | Upgrades | $20 | +5.60% | Sep 15, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | -4.96% | Aug 27, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +10.88% | Aug 22, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $28 → $18 | Strong Buy → Hold | Downgrades | $28 → $18 | -4.96% | Aug 20, 2025 |
| Baird | Baird | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +10.88% | Jul 30, 2025 |
Financial Forecast
Revenue This Year
2.79B
from 2.70B
Increased by 3.39%
Revenue Next Year
2.89B
from 2.79B
Increased by 3.44%
EPS This Year
0.23
from 0.36
Decreased by -34.51%
EPS Next Year
0.28
from 0.23
Increased by 20.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.0B | 3.2B | ||
| Avg | 2.8B | 2.9B | ||
| Low | 2.7B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 10.9% | 13.5% | ||
| Avg | 3.4% | 3.4% | ||
| Low | -1.3% | -3.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.33 | 0.38 | |||
| Avg | 0.23 | 0.28 | |||
| Low | 0.19 | 0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.2% | 61.0% | |||
| Avg | -34.5% | 21.0% | |||
| Low | -48.1% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.